Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

Clinical trial NCT05344248 · COMPLETED

Trial details

NCT number: NCT05344248
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Moderate to Severe Psoriasis

Start date: 2021-01-20
Primary completion: 2022-10-28
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.